Hydromadinone
Clinical data | |
---|---|
ATC code | None |
Identifiers | |
| |
CAS Number | 16469-74-2 |
PubChem (CID) | 216252 |
ChemSpider | 187450 |
ChEMBL | CHEMBL2104256 |
Chemical and physical data | |
Formula | C21H29ClO3 |
Molar mass | 364.906 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Hydromadinone (INN), also known as 6α-chloro-17α-hydroxyprogesterone, is a steroidal progestin of the 17α-hydroxyprogesterone group which was patented in 1967 but was never marketed.[1] The C17α acetate ester of hydromadinone, hydromadinone acetate, also exists, but similarly was never marketed.[1]
See also
References
- 1 2 C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. p. 1037. ISBN 978-0-412-46630-4.
This article is issued from Wikipedia - version of the 12/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.